Research brief · 2026-09-09
Is 'Food Noise' a Real, Measurable Thing?
"Food noise" is not a clinical term. It came from patients and clinicians describing what changed when they started a GLP-1 medication: the constant background chatter about food went quiet. Semaglutide and tirzepatide, the prescription medications most often mentioned, are FDA-approved for type 2 diabetes and chronic weight management. The question researchers are now chasing is whether food noise can be measured at all.
The first purpose-built tool is a five-item Food Noise Questionnaire scored from 0 to 20. The INFORM survey, published in Advances in Therapy in 2026, applied it retrospectively to 550 US adults using semaglutide. Median recalled score before treatment was 13; the median at the time of the survey was 6. The obvious weakness is that people were remembering how they felt months or years earlier, which invites recall bias in exactly the direction being measured.
A 2026 Purdue study in Physiology and Behavior took a more controlled approach, comparing people eligible for treatment but not yet on it with one-month and six-month users. Food noise scores were significantly lower in the six-month group, and both user groups needed a more concentrated solution to detect sweetness. That is a physiological measurement, not just self-report.
On a much longer timeline, STEP 5, a two-year randomized trial published in Obesity in 2023, used the older, validated Control of Eating Questionnaire and found craving control improved on semaglutide versus placebo at every checkpoint. Yet the CRAVE study, a 28-person real-world cohort in 2026, used a different validated craving scale and found no significant overall change after 24 weeks, though people who started with the most cravings saw the biggest drop.
The limit is measurement. The Food Noise Questionnaire is new and not fully validated, different instruments give different answers, no human imaging study has confirmed a brain mechanism, and nobody has tracked what happens to food noise after stopping. Questions about these medications belong with a physician.
Sources
- Arnaut T et al., INFORM survey: retrospective assessment of food noise after semaglutide
- Advances in Therapy 2026
- Rutigliani G, Mattes RD, GLP-1 receptor agonists and chemosensory function
- Physiology & Behavior 2026
- Wharton S et al., STEP 5: two-year effect of semaglutide on control of eating
- Obesity 2023
- Babazadeh D et al., CRAVE study: food cravings during GLP-1 therapy
- Obesity Pillars 2026
Peptide Proof reports what studies found. We do not give medical advice, dosing guidance, or treatment recommendations.